CRISPR-Cas System: A Promising Diagnostic Tool for Covid-19

Saeedeh Ebrahimi; Hashem Khanbabaei; Samaneh Abbasi; Mona Fani; Saber   Soltani; Milad  Zandi; Zahra Najafimemar

doi:10.18502/ajmb.v14i1.8165

Saeedeh Ebrahimi Department of Medical Microbiology (Bacteriology & Virology), Afzalipour Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran
Hashem Khanbabaei Department of Radiologic Technology, Faculty of Allied Medicine, Kerman University of Medical Sciences, Kerman, Iran
Samaneh Abbasi Abadan University of Medical Sciences, Abadan, Iran
Mona Fani Department of Pathobiology and Laboratory Sciences, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran
Saber Soltani Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
Milad Zandi Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
Zahra Najafimemar Infectious Diseases Research Center, Golestan University of Medical Sciences, Gorgan, Iran

DOI: https://doi.org/10.18502/ajmb.v14i1.8165

Keywords: COVID-19, CRISPR-Cas systems, SARS-CoV-2

Abstract

More than a year has passed since the beginning of the 2019 novel coronavirus diseases (COVID-19) pandemic which has created massive problems globally affecting all aspects of people's life. Due to the emergence of new strains of the SARS-CoV-2, pandemic risk still remains, despite the start of vaccination. Therefore, rapid diagnostic tests are essential to control infection, improve clinical care and stop the spread of the disease. Recently CRISPR-based diagnostic tools have facilitated rapid diagnostic. Here, we review the diagnostic applications of CRISPR-Cas system in COVID-19.